- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05525533
Supporting Young Women's Reproductive Health by Harnessing Prosociality Among Drug Shopkeepers
June 18, 2025 updated by: University of California, San Francisco
The goal of the study is to operationalize and test the preliminary impact of providing regular customer feedback from adolescent girls and young women (AGYW) to drug shopkeepers on the distribution of contraceptives and HIV self-testing to AGYW over 12 months.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The investigators will cross-randomize 120 drug shops enrolled in the parent Malkia Klabu effectiveness cluster-randomized controlled trial (CRCT; NCT05357144), stratified by CRCT study arm, to one of three initial conditions: 1.
No feedback.
AGYW customer feedback will be collected, but not shared with the shopkeeper.
2. Private feedback.
Biweekly summarized reports of AGYW customer feedback will be given directly to shopkeepers.
3. Public feedback: Shopkeepers will get biweekly summarized reports of AGYW customer feedback, gold stars reflecting the level of AGYW customer feedback (e.g., 1-5 star rating) will be placed in the shop in a visible location, and shopkeepers will be invited to an awards ceremony every 6 months to recognize shopkeepers who receive high levels of positive AGYW customer feedback.
The investigators will phase in the 2 interventions (Private and Public Feedback) on a staggered basis to control for both shop-specific and time-specific trends for the primary outcomes.
Study Type
Interventional
Enrollment (Actual)
144
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mwanza, Tanzania
- Mwanza Province
-
Shinyanga, Tanzania
- Shinyanga
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Shopkeepers enrolled in the parent CRCT
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: No feedback
AGYW customer feedback will be collected but not shared with shopkeepers
|
The investigators will collect AGYW customer feedback using a short USSD-based survey and randomize whether shopkeepers receive 1) No feedback; 2) Private feedback; or 3) Public feedback
|
|
Experimental: Private feedback
Biweekly summarized reports of AGYW customer feedback will be given directly to shopkeepers
|
The investigators will collect AGYW customer feedback using a short USSD-based survey and randomize whether shopkeepers receive 1) No feedback; 2) Private feedback; or 3) Public feedback
|
|
Experimental: Public feedback
Shopkeepers will get biweekly summarized reports of AGYW customer feedback, gold stars reflecting the level of AGYW customer feedback (e.g., 1-5 star rating) will be placed in the shop in a visible location, and shopkeepers will be invited to an awards ceremony every 6 months to recognize shopkeepers who receive high levels of positive AGYW customer feedback
|
The investigators will collect AGYW customer feedback using a short USSD-based survey and randomize whether shopkeepers receive 1) No feedback; 2) Private feedback; or 3) Public feedback
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantity of HIV Self-test Kits Distributed
Time Frame: 12 months
|
Mean number of HIV self-test kits sold per shop every month
|
12 months
|
|
Quantity of HIV Self-test Kits Distributed
Time Frame: 18 months
|
Mean number of HIV self-test kits distributed per shop every 2 weeks
|
18 months
|
|
Quantity of Sexual and Reproductive Health Products Sold
Time Frame: 12 months
|
Mean number of sexual and reproductive health products sold per shop every month
|
12 months
|
|
Quantity of Contraceptives Distributed
Time Frame: 18 months
|
Mean number of contraceptives distributed per shop every 2 weeks
|
18 months
|
|
Quantity of All Products Sold
Time Frame: 12 months
|
Mean number of all products sold per shop per month
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantity of Condoms Sold
Time Frame: 12 months
|
Mean number of condoms sold per shop every month
|
12 months
|
|
Quantity of Emergency Contraception Sold
Time Frame: 12 months
|
Mean number of emergency contraception sold per shop every month
|
12 months
|
|
Quantity of Oral Contraception Sold
Time Frame: 12 months
|
Mean number of oral contraception sold per shop every month
|
12 months
|
|
Quantity of Pregnancy Tests Sold
Time Frame: 12 months
|
Mean number of pregnancy tests sold per shop every month
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jenny X Liu, PhD, University of California, San Francisco
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hunter LA, McCoy SI, Rao A, Mnyippembe A, Hassan K, Njau P, Mfaume R, Liu JX. Designing drug shops for young women in Tanzania: applying human-centred design to facilitate access to HIV self-testing and contraception. Health Policy Plan. 2021 Nov 11;36(10):1562-1573. doi: 10.1093/heapol/czab084.
- Chiu C, Hunter LA, McCoy SI, Mfaume R, Njau P, Liu JX. Sales and pricing decisions for HIV self-test kits among local drug shops in Tanzania: a prospective cohort study. BMC Health Serv Res. 2021 May 6;21(1):434. doi: 10.1186/s12913-021-06432-1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2022
Primary Completion (Actual)
March 15, 2024
Study Completion (Actual)
March 15, 2024
Study Registration Dates
First Submitted
August 30, 2022
First Submitted That Met QC Criteria
August 30, 2022
First Posted (Actual)
September 1, 2022
Study Record Updates
Last Update Posted (Actual)
June 19, 2025
Last Update Submitted That Met QC Criteria
June 18, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- R03HD109561-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The investigators will make the data and associated documentation available to users upon request and only under a data-sharing agreement with the study team that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying the data after analyses are completed.
IPD Sharing Time Frame
The SP, SAP, and ICF will be made available on the Open Science Framework (OSF) within 12 months recruitment.
Study results will be posted to OSF and Clinical Trials within 12 months of completion of data collection.
IPD Sharing Access Criteria
Everything posted to OSF and Clinical Trials will be made publicly available.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiv
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
Clinical Trials on Harnessing prosocial and social image motivations for behavior change
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedObesity | Overweight | Overweight and ObesityUnited States
-
National Research Centre, EgyptEgyptian Liver HospitalCompletedHepatitis C and B VIRUS Screening, Awareness and Behavior Assessment and Evaluation for All Inhabitants Above Twelve Years of Al Othmaneya Village
-
University of California, San FranciscoCompletedPhysical InactivityUnited States
-
Massachusetts Institute of TechnologyMcGill University; United States Agency for International Development (USAID); Kehea... and other collaboratorsCompletedTuberculosis | Adherence, Medication | Drug-resistant Tuberculosis | Adherence, PatientKenya
-
Boston Medical CenterNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); The Fenway InstituteUnknownMedication Adherence | Body Image DisturbanceUnited States
-
University Health Network, TorontoSunnybrook Health Sciences Centre; University of British Columbia; Nova Scotia... and other collaboratorsUnknownChronic DiseaseCanada
-
VA Office of Research and DevelopmentRecruitingSocial Anxiety DisorderUnited States
-
Karolinska InstitutetCompletedStroke | Transient Ischemic AttackSweden
-
University of California, BerkeleyCompletedEveningness/SleepUnited States